RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Change in Fatigue and Correlations with Clinical Outcome in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib in the Bolt Study
Guminski, A., Stull, D., Houghton, K., Gutzmer, R., Migden, MR., Dirix, L., Lewis, KD., Combemale, P., Herd, RM., Kudchadkar, R., Trefzer, U., Sellami, D., Lear, J., & Dummer, R. (2016). Change in Fatigue and Correlations with Clinical Outcome in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib in the Bolt Study. Value in Health, 19(3), A159-A159. https://doi.org/10.1016/j.jval.2016.03.1474
Differential change in fatigue in patients treated with sonidegib in BOLT correlated with geographic region, performance status, metastatic burden, and treatment response. Increase in fatigue was lower in patients responding to treatment. These data support the clinical benefit observed with sonidegib in patients with advanced BCC.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.